Retrospective analysis of telemedicine consultations conducted in pregnant and puerperal women with novel coronavirus infection COVID-19
- 作者: Shabanova N.1, Pyregov A.1, Nikolaeva A.1, Bembeeva B.1, Skorobogaty A.1, Chubarov V.1, Denisov P.1, Klimov V.1, Pekarev O.1, Polibin R.2, Priputnevich T.1
-
隶属关系:
- Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
- I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)
- 期: 编号 4 (2023)
- 页面: 50-57
- 栏目: Original Articles
- URL: https://journals.rcsi.science/0300-9092/article/view/258553
- DOI: https://doi.org/10.18565/aig.2022.317
- ID: 258553
如何引用文章
详细
Objective: To evaluate the incidence of prescribing antibacterial agents (ABA) and the results of microbiological examination in pregnant and puerperal women with COVID-19 by analyzing the electronic records of telemedicine consultations (TMC) in patients from different regions of the Russian Federation.
Materials and methods: A retrospective analysis was done on 2500 pregnant and puerperal women from the database of patients with COVID-19 who received TMC between January and July 2021. The analysis included age, gestational age, medical history, chest computed tomography (chest CT), respiratory support, laboratory test results, frequency of microbiological studies, and ABA administration.
Results: This analysis revealed that 78.8%, 49.6%, and 55.8% of pregnant and puerperal COVID-19 patients were prescribed antibiotics, antifungals, and glucocorticoids, respectively. In microbiological testing, Candida albicans was the most frequently isolated microorganism (30.4 %). The most common gram-positive microorganisms were Staphylococcus spp. (18.8%), and Streptococcus spp. (15.9%), and Acinetobacter spp. among the gram-negative (14,5%). Acinetobacter baumannii accounted for 10.1% of the isolates. Klebsiella pneumoniae accounted for 11.6% of the cases.
Conclusion: The retrospective analysis showed that although microbiological testing was important, it was performed in only 4% of the cases. ABA were used in 78.8% of the cases, and broad-spectrum and reserve drugs were the most common choice. Antifungals were used in 49.6% of patients. Prescribing occurred immediately upon admission to the hospital without confirmation of a bacterial or fungal infection.
作者简介
Natalia Shabanova
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
编辑信件的主要联系方式.
Email: n_shabanova@oparina4.ru
ORCID iD: 0000-0001-6838-3616
PhD, Associate Professor, Head of the Unit of Clinical Pharmacology, Institute of Microbiology, Antimicrobial Therapy and Epidemiology
俄罗斯联邦, MoscowAlexey Pyregov
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: a_pyregov@oparina4.ru
Dr. Med. Sci., Professor, Director of the Institute of Anesthesiology-Resuscitation and Transfusiology
俄罗斯联邦, MoscowAnastasia Nikolaeva
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: a_nikolaeva@oparina4.ru
PhD, Chief Physician
俄罗斯联邦, MoscowBayr Bembeeva
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: b_bembeeva@oparina4.ru
ORCID iD: 0000-0002-8820-9903
bacteriologist at the Laboratory of Medical Microbiology, Institute of Microbiology, Antimicrobial Therapy and Epidemiology
俄罗斯联邦, MoscowAlexey Skorobogaty
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: a_skorobogatiy@oparina4.ru
ORCID iD: 0000-0003-2137-6421
Junior Researcher at the Unit of Clinical Pharmacology, Institute of Microbiology, Antimicrobial Therapy and Epidemiology
俄罗斯联邦, MoscowValery Chubarov
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: v_chubarov@oparina4.ru
Head of Epidemiological Surveillance Department, Institute of Microbiology, Antimicrobial Therapy and Epidemiology
俄罗斯联邦, MoscowPavel Denisov
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: pa_denisov@oparina4.ru
ORCID iD: 0000-0003-1813-6718
Researcher at the Laboratory of Bioinformatic Analysis, Institute of Microbiology, Antimicrobial Therapy and Epidemiology
俄罗斯联邦, MoscowVladimir Klimov
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: va_klimov@oparina4.ru
ORCID iD: 0000-0002-4699-7614
PhD, Head of the Service for Organization of Medical Care and Information Service
俄罗斯联邦, MoscowOleg Pekarev
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: o_pekarev@oparina4.ru
ORCID iD: 0000-0001-7122-6830
Dr. Med. Sci., Professor, Deputy Director of the Institute of Obstetrics
俄罗斯联邦, MoscowRoman Polibin
I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)
Email: n_shabanova@oparina4.ru
ORCID iD: 0000-0003-4146-4787
PhD, Associate Professor, Associate Professor at the Department of Epidemiology and Evidence-Based Medicine
俄罗斯联邦, MoscowTatiana Priputnevich
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: priput1@gmail.com
ORCID iD: 0000-0002-4126-9730
Dr. Med. Sci., Corresponding Member of the RAS, Director of the Institute of Microbiology, Antimicrobial Therapy and Epidemiology
俄罗斯联邦, Moscow参考
- Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020; 382(18): 1708-20. https://dx.doi.org/10.1056/NEJMoa2002032.
- Nikiforov V.V., Suranova T.G., Chernobrovkina T.Ya., Yankovskaya Ya.D., Burova S.V. New coronavirus infection (Covid-19): clinical and epidemiological aspects. The Russian Archives of Internal Medicine. 2020; 10(2): 87-93. (in Russian). https://dx.doi.org/10.20514/ 2226-6704-2020-10-2-87-93.
- Briko N.I., Kagramanyan I.N., Nikiforov V.V., Suranova T.G. Chernyavskaya O.P., Polezhaeva N.A. Pandemic COVID-19. Prevention measures in the Russian Federation. Epidemiology and Vaccinal Prevention. 2020; 19(2): 4-12. (in Russian). https://dx.doi.org/10.31631/2073-3046-2020-19-2-4-12.
- Shchelkanov M.Yu., Kolobukhina L.V., Burgasova O.A., Kruzhkova I.S., Maleev V.V. COVID-19: etiology, clinical picture, treatment. Russian Journal of Infection and Immunity. 2020; 10(3): 421-45. (in Russian). https://dx.doi.org/10.15789/2220-7619-CEC-1473.
- Kister G.S. Morphology and mechanisms of prenatal and perinatal viral infections. EURO Rep. Stud. 1985; 93: 3-16.
- Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev. Biochem. 2000; 69: 531-69. https://dx.doi.org/10.1146/annurev.biochem.69.1.531.
- Li Z., Ren A., Liu J., Pei L., Zhang L., Guo Z. Maternal flu or fever, medication use, and neural tube defects a population-based case-control study in Northern China. Birth Defect Res. A Clin. Mol. Teatol. 2007; 79(4): 295-300. https://dx.doi.org/10.1002/bdra.20342.
- Wenling Y., Junchao Q., Xiao Z., Ouyang S. Pregnancy and COVID-19: management and challenges. Rev. Inst. Med. Trop. de Sao Paulo. 2020; 62: e62. https://dx.doi.org/10.1590/S1678-9946202062062.
- Priputnevich T.V., Gordeev A.B., Lyubasovskaya L.A., Shabanova N.E. The novel coronavirus SARS-CoV-2 and pregnancy: literature review. Obstetrics and Gynecology. 2020; (5): 6-12. (in Russian). https://dx.doi.org/10.18565/aig.2020.5.6-12.
- Sharifipour E., Shams S., Esmkhani M., Khodadadi J., Fotouhi-Ardakani R., Koohpaei A. et al. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC Infect. Dis. 2020; 20(1): 646. https://dx.doi.org/10.1186/s12879-020-05374-z.
- Lansbury L., Lim B., Baskaran V., Lim W.S. Co-infections in people with COVID- 19: a systematic review and meta-analysis. J. Infect. 2020; 81: 266-75. https://dx.doi.org/10.1016/j.jinf.2020.05.046.
- Rawson T.M., Moore L.S.P., Zhu N., Ranganathan N., Skolimowska K., Gilchrist M. et al Clin. Infect. Dis. 2020; 71(9): 2459-68. https://dx.doi.org/10.1093/cid/ciaa530.
- Langford B.J., So M., Raybardhan S., Leung V., Westwood D., MacFadden D.R. et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin. Microbiol. Infect. 2020; 26(12): 1622-9. https://dx.doi.org/10.1016/j.cmi.2020.07.016.
- MacIntyre C.R., Chughtai A.A., Barnes M., Ridda I., Seale H., Toms R. The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09. BMC Infect. Dis. 2018; 18(1): 637. https://dx.doi.org/10.1186/s12879-018-3548-0.
- Zhou Y., Chi J., Lv W., Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab. Res. Rev. 2021; 37(2): e3377. https://dx.doi.org/10.1002/dmrr.3377.
- Langford B.J., So M., Raybardhan S., Leung V., Soucy J.R., Westwood D. et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin. Microbiol. Infect. 2021; 27(4): 520-31. https://dx.doi.org/10.1016/j.cmi.2020.12.018.
- Karoli N.A., Aparkina A.V., Grigoryeva E.V., Magdeeva N.A., Nikitina N.M., Smirnova N.D., Rebrov A.P. Antibacterial Therapy of Patients With COVID-19 During The Outpatient and Hospital Stages. Antibiotics and Chemotherapy. 2022; 67(1-2): 24-31. (in Russian). https://dx.doi.org/10.37489/0235-2990-2022-67-1-2-24-31.
- Abou Ghayda R., Li H., Lee K.H., Lee H.W., Hong S.H., Kwak M. et al. COVID-19 and adverse pregnancy outcome: a systematic review of 104 cases. J. Clin. Med. 2020; 9(11): 3441. https://dx.doi.org/10.3390/jcm9113441.
- Russell C.D., Fairfield C.J., Drake T.M., Turtle L., Seaton R.A., Wootton D.G.; ISARIC4C investigators. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study. Lancet Microbe. 2021; 2(8): e354-65. https://dx.doi.org/10.1016/ S2666-5247(21)00090-2.